Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DUT | P33316 | 2/20 | 0.50 |
| ▸ | P2RY2 | P41231 | 14/20 | 0.49 |
| ▸ | P2RY4 | P51582 | 8/20 | 0.49 |
| ▸ | POLA1 | P09884 | 1/20 | 0.47 |
| ▸ | P2RY6 | Q15077 | 6/20 | 0.46 |
| ▸ | P2RY14 | Q15391 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27341456 | 0.86 | P2RY2 (0.58) | DUTP2RY2P2RY4POLA1P2RY6 | |
| SCHEMBL4348233 | 0.85 | P2RY2 (0.51) | DUTP2RY2P2RY4POLA1P2RY6 | |
| SCHEMBL2811543 | 0.85 | DUT (0.61) | DUTP2RY2P2RY4POLA1P2RY6 | |
| SCHEMBL3487624 | 0.84 | POLB (0.45) | POLA1 | |
| SCHEMBL5285299 | 0.84 | POLB (0.57) | POLA1 | |
| SCHEMBL14913972 | 0.84 | DUT (0.51) | DUTP2RY2P2RY4POLA1P2RY6 | |
| SCHEMBL8600344 | 0.83 | DUT (0.47) | DUTP2RY2P2RY4POLA1P2RY6 | |
| SCHEMBL29431049 | 0.83 | DUT (0.56) | DUTP2RY2P2RY4POLA1P2RY6 | |
| SCHEMBL95679 | 0.82 | P2RY2 (0.44) | DUTP2RY2P2RY4POLA1P2RY6 | |
| SCHEMBL8099833 | 0.80 | DUT (0.59) | DUTP2RY2P2RY4P2RY6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1885876-A2 | MACROMOLECULAR NUCLEOTIDE LINKS AND METHODS FOR THEIR USE | Genovoxx GmbH (DE) | 2008-02-13 | — | — | EP | disclosed |
| WO-2006097320-A2 | MACROMOLECULAR NUCLEOTIDE LINKS AND METHODS FOR THEIR USE | GENOVOXX GMBH (DE) | 2006-09-21 | — | — | WO | disclosed |